151
|
Dean MPM, Cao Y, Liu X, Wall S, Zhu D, Mankowsky R, Thampy V, Chen XM, Vale JG, Casa D, Kim J, Said AH, Juhas P, Alonso-Mori R, Glownia JM, Robert A, Robinson J, Sikorski M, Song S, Kozina M, Lemke H, Patthey L, Owada S, Katayama T, Yabashi M, Tanaka Y, Togashi T, Liu J, Rayan Serrao C, Kim BJ, Huber L, Chang CL, McMorrow DF, Först M, Hill JP. Ultrafast energy- and momentum-resolved dynamics of magnetic correlations in the photo-doped Mott insulator Sr2IrO4. Nat Mater 2016; 15:601-5. [PMID: 27159018 DOI: 10.1038/nmat4641] [Citation(s) in RCA: 45] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/08/2015] [Accepted: 04/07/2016] [Indexed: 05/07/2023]
Abstract
Measuring how the magnetic correlations evolve in doped Mott insulators has greatly improved our understanding of the pseudogap, non-Fermi liquids and high-temperature superconductivity. Recently, photo-excitation has been used to induce similarly exotic states transiently. However, the lack of available probes of magnetic correlations in the time domain hinders our understanding of these photo-induced states and how they could be controlled. Here, we implement magnetic resonant inelastic X-ray scattering at a free-electron laser to directly determine the magnetic dynamics after photo-doping the Mott insulator Sr2IrO4. We find that the non-equilibrium state, 2 ps after the excitation, exhibits strongly suppressed long-range magnetic order, but hosts photo-carriers that induce strong, non-thermal magnetic correlations. These two-dimensional (2D) in-plane Néel correlations recover within a few picoseconds, whereas the three-dimensional (3D) long-range magnetic order restores on a fluence-dependent timescale of a few hundred picoseconds. The marked difference in these two timescales implies that the dimensionality of magnetic correlations is vital for our understanding of ultrafast magnetic dynamics.
Collapse
Affiliation(s)
- M P M Dean
- Department of Condensed Matter Physics and Materials Science, Brookhaven National Laboratory, Upton, New York 11973, USA
| | - Y Cao
- Department of Condensed Matter Physics and Materials Science, Brookhaven National Laboratory, Upton, New York 11973, USA
| | - X Liu
- Beijing National Laboratory for Condensed Matter Physics and Institute of Physics, Chinese Academy of Sciences, Beijing 100190, China
- Collaborative Innovation Center of Quantum Matter, Beijing, China
| | - S Wall
- ICFO-Institut de Ciències Fotòniques, The Barcelona Institute of Science and Technology, 08860 Castelldefels (Barcelona), Spain
| | - D Zhu
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - R Mankowsky
- Max Planck Institute for the Structure and Dynamics of Matter, D-22761 Hamburg, Germany
- Center for Free Electron Laser Science, D-22761 Hamburg, Germany
| | - V Thampy
- Department of Condensed Matter Physics and Materials Science, Brookhaven National Laboratory, Upton, New York 11973, USA
| | - X M Chen
- Department of Condensed Matter Physics and Materials Science, Brookhaven National Laboratory, Upton, New York 11973, USA
| | - J G Vale
- London Centre for Nanotechnology and Department of Physics and Astronomy, University College London, London WC1E 6BT, UK
| | - D Casa
- Advanced Photon Source, Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - Jungho Kim
- Advanced Photon Source, Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - A H Said
- Advanced Photon Source, Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - P Juhas
- Department of Condensed Matter Physics and Materials Science, Brookhaven National Laboratory, Upton, New York 11973, USA
| | - R Alonso-Mori
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - J M Glownia
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - A Robert
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - J Robinson
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - M Sikorski
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - S Song
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - M Kozina
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - H Lemke
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - L Patthey
- SwissFEL, Paul Scherrer Institut, CH-5232 Villigen PSI, Switzerland
| | - S Owada
- RIKEN SPring-8 Center, Sayo, Hyogo 679-5148, Japan
| | - T Katayama
- Japan Synchrotron Radiation Institute, 1-1-1 Kouto, Sayo-cho, Sayo-gun, Hyogo 679-5198, Japan
| | - M Yabashi
- RIKEN SPring-8 Center, Sayo, Hyogo 679-5148, Japan
| | | | - T Togashi
- Japan Synchrotron Radiation Institute, 1-1-1 Kouto, Sayo-cho, Sayo-gun, Hyogo 679-5198, Japan
| | - J Liu
- Department of Physics &Astronomy, University of Tennessee, Knoxville, Tennessee 37996, USA
| | - C Rayan Serrao
- Department of Electrical Engineering and Computer Sciences, University of California, Berkeley, California 94720, USA
| | - B J Kim
- Max Planck Institute for Solid State Research, D-70569 Stuttgart, Germany
| | - L Huber
- Institute for Quantum Electronics, ETH Zurich, CH-8093 Zurich, Switzerland
| | - C-L Chang
- Zernike Institute for Advanced Materials, University of Groningen, Groningen, NL 9747AG, The Netherlands
| | - D F McMorrow
- London Centre for Nanotechnology and Department of Physics and Astronomy, University College London, London WC1E 6BT, UK
| | - M Först
- Max Planck Institute for the Structure and Dynamics of Matter, D-22761 Hamburg, Germany
- Center for Free Electron Laser Science, D-22761 Hamburg, Germany
| | - J P Hill
- Department of Condensed Matter Physics and Materials Science, Brookhaven National Laboratory, Upton, New York 11973, USA
| |
Collapse
|
152
|
Lu Y, Li P, Gan W, Zhao X, Shen S, Feng W, Xu Q, Bi Y, Guo H, Zhu D. Clinical and Pathological Characteristics of Hypertensive and Normotensive Adrenal Pheochromocytomas. Exp Clin Endocrinol Diabetes 2016; 124:372-9. [PMID: 27219882 DOI: 10.1055/s-0042-100911] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Affiliation(s)
- Y. Lu
- Department of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University Medical School, Nanjing, China
| | - P. Li
- Department of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University Medical School, Nanjing, China
| | - W. Gan
- Department of Urology, Drum Tower Hospital Affiliated to Nanjing University Medical School, Nanjing, China
| | - X. Zhao
- Department of Urology, Drum Tower Hospital Affiliated to Nanjing University Medical School, Nanjing, China
| | - S. Shen
- Department of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University Medical School, Nanjing, China
| | - W. Feng
- Department of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University Medical School, Nanjing, China
| | - Q. Xu
- Department of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University Medical School, Nanjing, China
| | - Y. Bi
- Department of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University Medical School, Nanjing, China
| | - H. Guo
- Department of Urology, Drum Tower Hospital Affiliated to Nanjing University Medical School, Nanjing, China
| | - D. Zhu
- Department of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University Medical School, Nanjing, China
| |
Collapse
|
153
|
Lopez P, Aguilar T, Wu R, Krishnan A, Kong D, Patel J, Javier H, Dang W, Wong D, Zhu D, Dodd J, Shad Y, Humayun M, Hinton D, Clegg D, Johnson L, Lin C, Hsu D, Couture L. 445. cGMP Compliant Production for Human Embryonic Stem Cell Derived Retinal Pigment Epithelial Cells on a Synthetic Substrate for the Treatment of Non-Neovascular Age-Related Macular Degeneration for Phase I Clinical Study. Mol Ther 2016. [DOI: 10.1016/s1525-0016(16)33254-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
154
|
Zhu D, Xa JY, Wang YL. [One case of salivary gland acinar cell carcinoma]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2016; 30:573-575. [PMID: 29871075 DOI: 10.13201/j.issn.1001-1781.2016.07.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 11/13/2015] [Indexed: 11/12/2022]
Abstract
Salivary gland acinar cell carcinoma is a rare malignancy. The main clinical manifestations of local painless mass slowly increasing, quality and tough or real, even poor activity limitations fixed part. Imaging lack of specificity, often solid lesions. Because salivary gland acinar cell carcinoma of the breast and Salivary gland origin mammary secretory carcinoma samples have similar structural characteristics, difficulties in clinical diagnosis in differentiating between the two, the final result depends on pathology diagnosis.
Collapse
|
155
|
Chen Y, Shen G, Huang Y, Zhang Y, Han Y, Wang R, Shen H, Su S, Lin N, Zhu D, Pei L, Zheng X, Wu J, Wang X, Liu W, Wong M, Tao S. Household air pollution and personal exposure risk of polycyclic aromatic hydrocarbons among rural residents in Shanxi, China. Indoor Air 2016; 26:246-258. [PMID: 25808453 DOI: 10.1111/ina.12204] [Citation(s) in RCA: 49] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/13/2015] [Accepted: 03/16/2015] [Indexed: 06/04/2023]
Abstract
Polycyclic aromatic hydrocarbons (PAHs) are a group of pollutants of widespread concerns. Gaseous and size-segregated particulate-phase PAHs were collected in indoor and outdoor air in rural households. Personal exposure was measured and compared to the ingestion exposure. The average concentrations of 28 parent PAHs and benzo(a)pyrene (BaP) were 9000 ± 8390 and 131 ± 236 ng/m(3) for kitchen, 2590 ± 2270 and 43 ± 95 ng/m(3) for living room, and 2800 ± 3890 and 1.6 ± 0.7 ng/m(3) for outdoor air, respectively. The mass percent of high molecular weight (HMW) compounds with 5-6 rings contributed 1.3% to total 28 parent PAHs. Relatively higher fractions of HMW PAHs were found in indoor air compared to outdoor air. Majorities of particle-bound PAHs were found in the finest PM0.25 , and the highest levels of fine PM0.25 -bound PAHs were in the kitchen using peat and wood as energy sources. The 24-h personal PAH exposure concentration was 2100 ± 1300 ng/m(3) . Considering energies, exposures to those using wood were the highest. The PAH inhalation exposure comprised up to about 30% in total PAH exposure through food ingestion and inhalation, and the population attributable fraction (PAF) for lung cancer in the region was 0.85%. The risks for inhaled and ingested intakes of PAHs were 1.0 × 10(-5) and 1.1 × 10(-5) , respectively.
Collapse
Affiliation(s)
- Y Chen
- Laboratory of Earth Surface Processes, College of Urban and Environmental Science, Peking University, Beijing, China
| | - G Shen
- Laboratory of Earth Surface Processes, College of Urban and Environmental Science, Peking University, Beijing, China
- Jiangsu Provincial Laboratory of Environmental Engineering, Jiangsu Academy of Environmental Sciences, Nanjing, China
| | - Y Huang
- Laboratory of Earth Surface Processes, College of Urban and Environmental Science, Peking University, Beijing, China
| | - Y Zhang
- Laboratory of Earth Surface Processes, College of Urban and Environmental Science, Peking University, Beijing, China
| | - Y Han
- Laboratory of Earth Surface Processes, College of Urban and Environmental Science, Peking University, Beijing, China
| | - R Wang
- Laboratory of Earth Surface Processes, College of Urban and Environmental Science, Peking University, Beijing, China
| | - H Shen
- Laboratory of Earth Surface Processes, College of Urban and Environmental Science, Peking University, Beijing, China
| | - S Su
- Laboratory of Earth Surface Processes, College of Urban and Environmental Science, Peking University, Beijing, China
| | - N Lin
- Laboratory of Earth Surface Processes, College of Urban and Environmental Science, Peking University, Beijing, China
| | - D Zhu
- Laboratory of Earth Surface Processes, College of Urban and Environmental Science, Peking University, Beijing, China
| | - L Pei
- Institute of Population Research, Peking University, Beijing, China
| | - X Zheng
- Institute of Population Research, Peking University, Beijing, China
| | - J Wu
- Institute of Population Research, Peking University, Beijing, China
| | - X Wang
- Laboratory of Earth Surface Processes, College of Urban and Environmental Science, Peking University, Beijing, China
| | - W Liu
- Laboratory of Earth Surface Processes, College of Urban and Environmental Science, Peking University, Beijing, China
| | - M Wong
- Consortium on Health, Environment, Education and Research (CHEER), Department of Science and Environmental Studies, Hong Kong Institute of Education, Hong Kong, China
| | - S Tao
- Laboratory of Earth Surface Processes, College of Urban and Environmental Science, Peking University, Beijing, China
| |
Collapse
|
156
|
Zhu J, Sun L, Ding B, Yang Y, Xu X, Liu W, Zhu D, Yang F, Zhang H, Hu F. Outbreak of NDM-1-producing Klebsiella pneumoniae ST76 and ST37 isolates in neonates. Eur J Clin Microbiol Infect Dis 2016; 35:611-8. [DOI: 10.1007/s10096-016-2578-z] [Citation(s) in RCA: 56] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2015] [Accepted: 01/04/2016] [Indexed: 11/30/2022]
|
157
|
Zhu D, Li R, Liu F, Xu H, Li B, Yuan Y, Saris P, Qiao M. Mu insertion in feuD
triggers the increase in nisin immunity in Lactococcus lactis
subsp. lactis
N8. J Appl Microbiol 2016; 120:402-12. [DOI: 10.1111/jam.13015] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2015] [Revised: 10/21/2015] [Accepted: 11/20/2015] [Indexed: 11/29/2022]
Affiliation(s)
- D. Zhu
- Key Laboratory of Molecular Microbiology and Technology; Ministry of Education; Nankai University; Tianjin China
| | - R. Li
- School of Life Sciences and Technology; ShanghaiTech University; Shanghai China
| | - F. Liu
- Key Laboratory of Molecular Microbiology and Technology; Ministry of Education; Nankai University; Tianjin China
| | - H. Xu
- Key Laboratory of Molecular Microbiology and Technology; Ministry of Education; Nankai University; Tianjin China
| | - B. Li
- Key Laboratory of Systems Bioengineering; Ministry of Education; Department of Pharmaceutical Engineering; Tianjin University; Tianjin China
| | - Y. Yuan
- Key Laboratory of Systems Bioengineering; Ministry of Education; Department of Pharmaceutical Engineering; Tianjin University; Tianjin China
| | - P.E.J. Saris
- Department of Food and Environmental Sciences; University of Helsinki; Helsinki Finland
| | - M. Qiao
- Key Laboratory of Molecular Microbiology and Technology; Ministry of Education; Nankai University; Tianjin China
| |
Collapse
|
158
|
Zhang B, Zhang Y, Zhang J, Yan X, Zhu D. Step by step crystal-to-crystal transformation from 1D K 2Cu(C 2O 4) 2(H 2O) 4(1) to 1D K 2Cu(C 2O 4) 2(H 2O) 2(2) and then 1D K 2Cu(C 2O 4) 2(3) by dehydration. CrystEngComm 2016. [DOI: 10.1039/c6ce00786d] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
159
|
de la Fuente MI, Young RJ, Rubel J, Rosenblum M, Tisnado J, Briggs S, Arevalo-Perez J, Cross JR, Campos C, Straley K, Zhu D, Dong C, Thomas A, Omuro AA, Nolan CP, Pentsova E, Kaley TJ, Oh JH, Noeske R, Maher E, Choi C, Gutin PH, Holodny AI, Yen K, DeAngelis LM, Mellinghoff IK, Thakur SB. Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma. Neuro Oncol 2015; 18:283-90. [PMID: 26691210 DOI: 10.1093/neuonc/nov307] [Citation(s) in RCA: 127] [Impact Index Per Article: 14.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2015] [Accepted: 11/14/2015] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND The majority of WHO grades II and III gliomas harbor a missense mutation in the metabolic gene isocitrate dehydrogenase (IDH) and accumulate the metabolite R-2-hydroxyglutarate (R-2HG). Prior studies showed that this metabolite can be detected in vivo using proton magnetic-resonance spectroscopy (MRS), but the sensitivity of this methodology and its clinical implications are unknown. METHODS We developed an MR imaging protocol to integrate 2HG-MRS into routine clinical glioma imaging and examined its performance in 89 consecutive glioma patients. RESULTS Detection of 2-hydroxyglutarate (2HG) in IDH-mutant gliomas was closely linked to tumor volume, with sensitivity ranging from 8% for small tumors (<3.4 mL) to 91% for larger tumors (>8 mL). In patients undergoing 2HG-MRS prior to surgery, tumor levels of 2HG corresponded with tumor cellularity but not with tumor grade or mitotic index. Cytoreductive therapy resulted in a gradual decrease in 2HG levels with kinetics that closely mirrored changes in tumor volume. CONCLUSIONS Our study demonstrates that 2HG-MRS can be linked with routine MR imaging to provide quantitative measurements of 2HG in glioma and may be useful as an imaging biomarker to monitor the abundance of IDH-mutant tumor cells noninvasively during glioma therapy and disease monitoring.
Collapse
Affiliation(s)
- Macarena I de la Fuente
- Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.)
| | - Robert J Young
- Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.)
| | - Jennifer Rubel
- Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.)
| | - Marc Rosenblum
- Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.)
| | - Jamie Tisnado
- Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.)
| | - Samuel Briggs
- Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.)
| | - Julio Arevalo-Perez
- Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.)
| | - Justin R Cross
- Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.)
| | - Carl Campos
- Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.)
| | - Kimberly Straley
- Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.)
| | - Dongwei Zhu
- Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.)
| | - Chuanhui Dong
- Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.)
| | - Alissa Thomas
- Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.)
| | - Antonio A Omuro
- Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.)
| | - Craig P Nolan
- Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.)
| | - Elena Pentsova
- Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.)
| | - Thomas J Kaley
- Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.)
| | - Jung H Oh
- Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.)
| | - Ralph Noeske
- Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.)
| | - Elizabeth Maher
- Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.)
| | - Changho Choi
- Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.)
| | - Philip H Gutin
- Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.)
| | - Andrei I Holodny
- Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.)
| | - Katharine Yen
- Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.)
| | - Lisa M DeAngelis
- Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.)
| | - Ingo K Mellinghoff
- Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.)
| | - Sunitha B Thakur
- Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.)
| |
Collapse
|
160
|
|
161
|
Luo Y, Li Q, Wang X, Yang F, Nong S, Li Q, Zhu D. Molecular Characterization and TRAP Analysis of Gene in Dendranthema morifolium. Cell Mol Biol (Noisy-le-grand) 2015; 61:119-122. [PMID: 26638892] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2015] [Accepted: 11/26/2015] [Indexed: 06/05/2023]
Abstract
The molecular maker system - TRAP was applied to develop a novel and more accurate method to identify the variety and establish the evolutionary relationship of different categories of Dendranthema morifolium. A software - GENESIS 2.4 was used to conduct the cluster analysis and genetic dendrogram establishment. The results showed that 202 different fragments were amplified with 6 pair primers using the TRAP marker system. The polymorphic fragments number is 45, which takes up to 22.3%. The cluster analysis showed that 4 materials used in this study can be classified into 2 main groups and 3 subgroups. The genetic identity is 0.0767 and the average genetic distance is 0.9236 among the four materials. A new tool using the TRAP marker system is more accurate and can be used to identify different categories of Dendranthema morifolium at molecular level.
Collapse
Affiliation(s)
- Y Luo
- Guangxi Medical University, Nanning Pharmaceutical college Guangxi China
| | - Q Li
- Guangxi Medical University, Nanning Pharmaceutical college Guangxi China
| | - X Wang
- Guangxi Medical University, Nanning Pharmaceutical college Guangxi China
| | - F Yang
- Guangxi Medical University, Nanning Pharmaceutical college Guangxi China
| | - S Nong
- Guangxi Medical University, Nanning Pharmaceutical college Guangxi China
| | - Q Li
- Guangxi Medical University, Nanning Pharmaceutical college Guangxi China
| | - D Zhu
- Guangxi Medical University, Nanning Pharmaceutical college Guangxi China
| |
Collapse
|
162
|
Sun Y, Li Q, Wang G, Zhu D, Chen J, Li P. Development of transcript-associated microsatellite markers in Ancherythoculter nigrocauda and cross-amplification in Culter alburnus. Genet Mol Res 2015; 14:14286-90. [PMID: 26600486 DOI: 10.4238/2015.november.13.12] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Twenty-eight polymorphic microsatellite markers were developed from the transcriptome of Ancherythoculter nigrocauda. These loci were used to characterize the genotypes of 48 individuals. The observed number of alleles per locus ranged from 5 to 11, with an average of 7.7. Expected and observed heterozygosities ranged from 0.437 to 0.978 and from 0.373 to 1.000, respectively. Four of these polymorphic microsatellite loci (HWB14, HWB18, HWB24, and HWB30) deviated significantly from the Hardy-Weinberg equilibrium after use of the sequential Bonferroni correction (P < 0.05). Twenty of the 28 loci could be successfully amplified in Culter alburnus. These novel markers will be useful for germplasm resource conservation and management of A. nigrocauda and C. alburnus.
Collapse
Affiliation(s)
- Y Sun
- Wuhan Aquaculture Science Research Institute, Wuhan, China
| | - Q Li
- Wuhan Aquaculture Science Research Institute, Wuhan, China
| | - G Wang
- Wuhan Aquaculture Science Research Institute, Wuhan, China
| | - D Zhu
- Wuhan Aquaculture Science Research Institute, Wuhan, China
| | - J Chen
- Wuhan Aquaculture Science Research Institute, Wuhan, China
| | - P Li
- Wuhan Aquaculture Science Research Institute, Wuhan, China
| |
Collapse
|
163
|
Gerber S, Jang H, Nojiri H, Matsuzawa S, Yasumura H, Bonn DA, Liang R, Hardy WN, Islam Z, Mehta A, Song S, Sikorski M, Stefanescu D, Feng Y, Kivelson SA, Devereaux TP, Shen ZX, Kao CC, Lee WS, Zhu D, Lee JS. Three-dimensional charge density wave order in YBa2Cu3O6.67 at high magnetic fields. Science 2015; 350:949-52. [PMID: 26541608 DOI: 10.1126/science.aac6257] [Citation(s) in RCA: 238] [Impact Index Per Article: 26.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2015] [Accepted: 09/30/2015] [Indexed: 11/02/2022]
Abstract
Charge density wave (CDW) correlations have been shown to universally exist in cuprate superconductors. However, their nature at high fields inferred from nuclear magnetic resonance is distinct from that measured with x-ray scattering at zero and low fields. We combined a pulsed magnet with an x-ray free-electron laser to characterize the CDW in YBa2Cu3O6.67 via x-ray scattering in fields of up to 28 tesla. While the zero-field CDW order, which develops at temperatures below ~150 kelvin, is essentially two dimensional, at lower temperature and beyond 15 tesla, another three-dimensionally ordered CDW emerges. The field-induced CDW appears around the zero-field superconducting transition temperature; in contrast, the incommensurate in-plane ordering vector is field-independent. This implies that the two forms of CDW and high-temperature superconductivity are intimately linked.
Collapse
Affiliation(s)
- S Gerber
- Stanford Institute for Materials and Energy Science, SLAC National Accelerator Laboratory and Stanford University, Menlo Park, CA 94025, USA
| | - H Jang
- Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, Menlo Park, CA 94025, USA
| | - H Nojiri
- Institute for Materials Research, Tohoku University, Katahira 2-1-1, Sendai, 980-8577, Japan
| | - S Matsuzawa
- Institute for Materials Research, Tohoku University, Katahira 2-1-1, Sendai, 980-8577, Japan
| | - H Yasumura
- Institute for Materials Research, Tohoku University, Katahira 2-1-1, Sendai, 980-8577, Japan
| | - D A Bonn
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia V6T 1Z1, Canada. Canadian Institute for Advanced Research, Toronto, Ontario M5G 1Z8, Canada
| | - R Liang
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia V6T 1Z1, Canada. Canadian Institute for Advanced Research, Toronto, Ontario M5G 1Z8, Canada
| | - W N Hardy
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia V6T 1Z1, Canada. Canadian Institute for Advanced Research, Toronto, Ontario M5G 1Z8, Canada
| | - Z Islam
- The Advanced Photon Source, Argonne National Laboratory, Argonne, IL 60439, USA
| | - A Mehta
- Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, Menlo Park, CA 94025, USA
| | - S Song
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, CA 94025, USA
| | - M Sikorski
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, CA 94025, USA
| | - D Stefanescu
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, CA 94025, USA
| | - Y Feng
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, CA 94025, USA
| | - S A Kivelson
- Geballe Laboratory for Advanced Materials, Departments of Physics and Applied Physics, Stanford University, Stanford, CA 94305, USA
| | - T P Devereaux
- Stanford Institute for Materials and Energy Science, SLAC National Accelerator Laboratory and Stanford University, Menlo Park, CA 94025, USA
| | - Z-X Shen
- Stanford Institute for Materials and Energy Science, SLAC National Accelerator Laboratory and Stanford University, Menlo Park, CA 94025, USA. Geballe Laboratory for Advanced Materials, Departments of Physics and Applied Physics, Stanford University, Stanford, CA 94305, USA
| | - C-C Kao
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025, USA
| | - W-S Lee
- Stanford Institute for Materials and Energy Science, SLAC National Accelerator Laboratory and Stanford University, Menlo Park, CA 94025, USA.
| | - D Zhu
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, CA 94025, USA.
| | - J-S Lee
- Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, Menlo Park, CA 94025, USA.
| |
Collapse
|
164
|
Wang D, Liu Y, Lu P, Zhu D, Zhu Y. 15-oxo-ETE-induced internal carotid artery constriction in hypoxic rats is mediated by potassium channels. Physiol Res 2015; 65:391-9. [PMID: 26447508 DOI: 10.33549/physiolres.933001] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
Abstract
Our own study as well as others have previously reported that hypoxia activates 15-lipoxygenase (15-LO) in the brain, causing a series of chain reactions, which exacerbates ischemic stroke. 15-hydroxyeicosatetraenoic acid (15-HETE) and 15-oxo-eicosatetraenoic acid (15-oxo-ETE/15-KETE) are 15-LO-specific metabolites of arachidonic acid (AA). 15-HETE was found to be rapidly converted into 15-oxo-ETE by 15-hydroxyprostaglandin dehydrogenase (15-PGDH) in some circumstances. We have demonstrated that 15-HETE promotes cerebral vasoconstriction during hypoxia. However, the effect of 15-oxo-ETE upon the contraction of cerebral vasculature remains unclear. To investigate this effect and to clarify the underlying mechanism, we performed immunohistochemistry and Western blot to test the expression of 15-PGDH in rat cerebral tissue, examined internal carotid artery (ICA) tension in isolated rat ICA rings. Western blot and reverse transcription polymerase chain reaction (RT-PCR) were used to analyze the expression of voltage-gated potassium (Kv) channels (Kv2.1, Kv1.5, and Kv1.1) in cultured cerebral arterial smooth muscle cells (CASMCs). The results showed that the levels of 15-PGDH expression were drastically elevated in the cerebral of rats with hypoxia, and 15-oxo-ETE enhanced ICA contraction in a dose-dependent manner. This effect was more significant in the hypoxic rats than in the normoxic rats. We also found that 15-oxo-ETE significantly attenuated the expression of Kv2.1 and Kv1.5, but not Kv1.1. In conclusion, these results suggest that 15-oxo-ETE leads to the contraction of the ICA, especially under hypoxic conditions and that specific Kv channels may play an important role in 15-oxo-ETE-induced ICA constriction.
Collapse
Affiliation(s)
- D Wang
- Department of Neurology, Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
| | | | | | | | | |
Collapse
|
165
|
Zhou XQ, Zhang YD, Zhao M, Zhang T, Zhu D, Bu DP, Wang JQ. Effect of dietary energy source and level on nutrient digestibility, rumen microbial protein synthesis, and milk performance in lactating dairy cows. J Dairy Sci 2015; 98:7209-17. [PMID: 26254527 DOI: 10.3168/jds.2015-9312] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2015] [Accepted: 06/19/2015] [Indexed: 11/19/2022]
Abstract
This study was conducted to examine the effects of dietary energy source and level on intake, digestion, rumen microbial protein synthesis, and milk production in lactating dairy cows, using corn stover as a forage source. Eight multiparous Holstein cows, 4 of which were fitted with rumen cannulas, were evaluated in a replicated 4 × 4 Latin square design, with each period lasting 21 d. The cows were randomly assigned into 4 treatment groups: low-energy (LE) ground corn (GC), LE steam-flaked corn (SFC), high-energy (HE) GC, and HE SFC. Changes to ruminal energy degradation rates were induced by feeding the cows diets of either finely ground corn or SFC as components of diets with the same total energy level. Milk yield, milk protein content and yield, and milk lactose yield all increased in response to higher levels of dietary energy, whereas contents of milk fat and lactose were unaffected. Cows fed HE diets had a higher crude microbial protein yield and total-tract apparent digestibility than those receiving LE diets. Milk yield, milk protein yield, and microbial protein yield were also higher when SFC replaced GC as the main energy source for lactating cows fed LE diets. These results suggest that an increased dietary energy level and ruminal degradation rate are beneficial to milk protein production, which we suggest is due to increased yields of microbial proteins, when cows are fed corn stover as a dietary forage source.
Collapse
Affiliation(s)
- X Q Zhou
- College of Animal Science and Technology, Northeast Agricultural University; Harbin 150030, P. R. China; State Key Laboratory of Animal Nutrition, Institute of Animal Science, Chinese Academy of Agricultural Sciences, Beijing, 100193, P. R. China
| | - Y D Zhang
- State Key Laboratory of Animal Nutrition, Institute of Animal Science, Chinese Academy of Agricultural Sciences, Beijing, 100193, P. R. China
| | - M Zhao
- State Key Laboratory of Animal Nutrition, Institute of Animal Science, Chinese Academy of Agricultural Sciences, Beijing, 100193, P. R. China
| | - T Zhang
- State Key Laboratory of Animal Nutrition, Institute of Animal Science, Chinese Academy of Agricultural Sciences, Beijing, 100193, P. R. China
| | - D Zhu
- State Key Laboratory of Animal Nutrition, Institute of Animal Science, Chinese Academy of Agricultural Sciences, Beijing, 100193, P. R. China
| | - D P Bu
- State Key Laboratory of Animal Nutrition, Institute of Animal Science, Chinese Academy of Agricultural Sciences, Beijing, 100193, P. R. China; Synergetic Innovation Center of Food Safety and Nutrition, Harbin, 150030, P. R. China; Chinese Academy of Agricultural Sciences-International Center for Research in Agroforestry, Joint Laboratory on Agroforestry and Sustainable Animal Husbandry, World Agroforestry Centre, East and Central Asia, Beijing 100193, P. R. China.
| | - J Q Wang
- College of Animal Science and Technology, Northeast Agricultural University; Harbin 150030, P. R. China; State Key Laboratory of Animal Nutrition, Institute of Animal Science, Chinese Academy of Agricultural Sciences, Beijing, 100193, P. R. China.
| |
Collapse
|
166
|
Zhuang M, Huang L, Zhu D, Peng X, Lin Z. Reirradiation of nasopharyngeal carcinoma focusing on volumetric modulated arcs with flattening filter-free beams. Br J Radiol 2015; 88:20140837. [PMID: 26032355 PMCID: PMC4651395 DOI: 10.1259/bjr.20140837] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2014] [Revised: 05/19/2015] [Accepted: 06/01/2015] [Indexed: 02/05/2023] Open
Abstract
OBJECTIVE The goal of this study was to assess the role of flattening filter-free (FFF) beams in volumetric modulated arc radiotherapy for patients with recurrent nasopharyngeal carcinoma (rNPC). METHODS 13 patients with rNPC were replanned for FFF RapidArc(®) (RA-FFF) and conventional RapidArc (RA) (Varian Medical Systems, Palo Alto, CA). Quantitative evaluation was performed for the planning target volume (PTV) and organs at risk (OARs). Phantom dose verifications, treatment delivery time and monitor units (MUs) were also assessed. RESULTS Each technique delivered similar doses to the PTV. RA-FFF had a better sparing effect on the brain stem and normal tissue when compared with RA, whereas RA provided lower mean doses to the skin. No significant difference between the two techniques could be established for other OAR parameters. Both techniques showed equally good gamma scores in dosimetric verification. RA-FFF required more MUs than RA, whereas the delivery time for RA-FFF was slightly shorter than for RA. CONCLUSION Both treatment plans met the planning objectives. Dose measurements also showed good agreement with computed doses. In addition to slightly faster delivery times, RA-FFF produced better sparing of brain stem and normal tissue with uncompromised target coverage compared with RA. ADVANCES IN KNOWLEDGE FFF beams have recently been assembled for clinical use. Our findings show RA-FFF is useful in the salvage treatment of rNPC owing to better brain stem and normal tissue sparing with uncompromised target coverage compared with RA. This may be beneficial in the case of tumour invasion close to the brain stem.
Collapse
|
167
|
Cui S, Guo L, Li X, Gu Y, Fu J, Dong L, Song H, Chen X, Lu Y, Hu C, Xiao F, Zhu D, Wu Z, Zhang Q. Clinical Safety and Preliminary Efficacy of Plasmid pUDK-HGF Expressing Human Hepatocyte Growth Factor (HGF) in Patients with Critical Limb Ischemia. Eur J Vasc Endovasc Surg 2015; 50:494-501. [PMID: 26122834 DOI: 10.1016/j.ejvs.2015.05.007] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2015] [Accepted: 05/20/2015] [Indexed: 10/23/2022]
Abstract
OBJECTIVE Critical limb ischemia (CLI) is the most severe form of peripheral arterial disease and a major unmet public health care need. This phase I clinical study was performed to assess the safety and preliminary efficacy of naked plasmid DNA (pUDK-HGF) expressing human hepatocyte growth factor (HGF) in patients with critical limb ischemia (CLI). DESIGN Twenty-one patients with CLI were enrolled and randomly divided into four dose groups (4-16 mg) to receive local injection of pUDK-HGF into ischemic calf and/or thigh muscles twice on days 1 and 15. Safety, including adverse events and physiological parameters, and preliminary efficacy, including pain severity score (VAS), ulcer size, transcutaneous oxygen pressure (TcPO2), and ankle brachial index (ABI), were evaluated throughout a 3 month follow up period. RESULTS All doses of pUDK-HGF were well tolerated by the patients. None of the adverse effects was considered to be related to pUDK-HGF injection. Two significant clinical results were observed after pUDK-HGF administration. The mean VAS value of all patients decreased from 4.52 at baseline to 0.30 (p < .01), and pain had disappeared in 14 out of 17 evaluable patients by day 91. Two of four ulcers had completely healed, with the other two patients having more than 25% ulcer size reduction in the long axis diameter. Of five patients with gangrene, one gangrenous wound had healed completely and two patients showed marked size reduction by day 91. The mean hemodynamic parameters (ABI, TcPO2) were also improved. CONCLUSION Intramuscular injection of pUDK-HGF is safe, and may provide symptomatic relief for CLI patients. A larger, randomized, double blinded phase II trial will provide more information on safety and efficacy.
Collapse
Affiliation(s)
- S Cui
- Vascular Surgery Department of Xuan Wu Hospital, Institute of Vascular Surgery, Capital Medical University, Beijing, China
| | - L Guo
- Vascular Surgery Department of Xuan Wu Hospital, Institute of Vascular Surgery, Capital Medical University, Beijing, China
| | - X Li
- Vascular Surgery Department of Xuan Wu Hospital, Institute of Vascular Surgery, Capital Medical University, Beijing, China
| | - Y Gu
- Vascular Surgery Department of Xuan Wu Hospital, Institute of Vascular Surgery, Capital Medical University, Beijing, China.
| | - J Fu
- Beijing Institute of Radiation Medicine, Beijing, China
| | - L Dong
- Beijing Institute of Radiation Medicine, Beijing, China
| | - H Song
- Beijing Institute of Radiation Medicine, Beijing, China
| | - X Chen
- Beijing Institute of Radiation Medicine, Beijing, China
| | - Y Lu
- Beijing Institute of Radiation Medicine, Beijing, China
| | - C Hu
- Beijing Institute of Radiation Medicine, Beijing, China
| | - F Xiao
- Beijing Institute of Radiation Medicine, Beijing, China
| | - D Zhu
- Humanwell Healthcare Group Co., Ltd., Wuhan, China
| | - Z Wu
- Beijing Institute of Radiation Medicine, Beijing, China
| | - Q Zhang
- Beijing Institute of Radiation Medicine, Beijing, China.
| |
Collapse
|
168
|
Minitti MP, Budarz JM, Kirrander A, Robinson JS, Ratner D, Lane TJ, Zhu D, Glownia JM, Kozina M, Lemke HT, Sikorski M, Feng Y, Nelson S, Saita K, Stankus B, Northey T, Hastings JB, Weber PM. Imaging Molecular Motion: Femtosecond X-Ray Scattering of an Electrocyclic Chemical Reaction. Phys Rev Lett 2015. [PMID: 26197134 DOI: 10.1103/physrevlett.114.255501] [Citation(s) in RCA: 141] [Impact Index Per Article: 15.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/13/2023]
Abstract
Structural rearrangements within single molecules occur on ultrafast time scales. Many aspects of molecular dynamics, such as the energy flow through excited states, have been studied using spectroscopic techniques, yet the goal to watch molecules evolve their geometrical structure in real time remains challenging. By mapping nuclear motions using femtosecond x-ray pulses, we have created real-space representations of the evolving dynamics during a well-known chemical reaction and show a series of time-sorted structural snapshots produced by ultrafast time-resolved hard x-ray scattering. A computational analysis optimally matches the series of scattering patterns produced by the x rays to a multitude of potential reaction paths. In so doing, we have made a critical step toward the goal of viewing chemical reactions on femtosecond time scales, opening a new direction in studies of ultrafast chemical reactions in the gas phase.
Collapse
Affiliation(s)
- M P Minitti
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - J M Budarz
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
- Brown University, Department of Chemistry, Providence, Rhode Island 02912, USA
| | - A Kirrander
- School of Chemistry, University of Edinburgh, Edinburgh EH9 3FJ, United Kingdom
| | - J S Robinson
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - D Ratner
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - T J Lane
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
- Stanford University, Department of Chemistry, Stanford, California 94305, USA
| | - D Zhu
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - J M Glownia
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - M Kozina
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - H T Lemke
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - M Sikorski
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - Y Feng
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - S Nelson
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - K Saita
- School of Chemistry, University of Edinburgh, Edinburgh EH9 3FJ, United Kingdom
| | - B Stankus
- Brown University, Department of Chemistry, Providence, Rhode Island 02912, USA
| | - T Northey
- School of Chemistry, University of Edinburgh, Edinburgh EH9 3FJ, United Kingdom
| | - J B Hastings
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - P M Weber
- Brown University, Department of Chemistry, Providence, Rhode Island 02912, USA
| |
Collapse
|
169
|
Gerber S, Kim KW, Zhang Y, Zhu D, Plonka N, Yi M, Dakovski GL, Leuenberger D, Kirchmann PS, Moore RG, Chollet M, Glownia JM, Feng Y, Lee JS, Mehta A, Kemper AF, Wolf T, Chuang YD, Hussain Z, Kao CC, Moritz B, Shen ZX, Devereaux TP, Lee WS. Direct characterization of photoinduced lattice dynamics in BaFe2As2. Nat Commun 2015; 6:7377. [PMID: 26051704 PMCID: PMC4468847 DOI: 10.1038/ncomms8377] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2014] [Accepted: 04/29/2015] [Indexed: 11/16/2022] Open
Abstract
Ultrafast light pulses can modify electronic properties of quantum materials by perturbing the underlying, intertwined degrees of freedom. In particular, iron-based superconductors exhibit a strong coupling among electronic nematic fluctuations, spins and the lattice, serving as a playground for ultrafast manipulation. Here we use time-resolved X-ray scattering to measure the lattice dynamics of photoexcited BaFe2As2. On optical excitation, no signature of an ultrafast change of the crystal symmetry is observed, but the lattice oscillates rapidly in time due to the coherent excitation of an A1g mode that modulates the Fe–As–Fe bond angle. We directly quantify the coherent lattice dynamics and show that even a small photoinduced lattice distortion can induce notable changes in the electronic and magnetic properties. Our analysis implies that transient structural modification can be an effective tool for manipulating the electronic properties of multi-orbital systems, where electronic instabilities are sensitive to the orbital character of bands. In BaFe2As2, the lattice couples strongly to the magnetic and electronic degrees of freedom, providing a way to control them. Here, by means of time-resolved X-ray scattering, the authors measure rapid lattice oscillations, which can induce changes in the material's electronic and magnetic properties.
Collapse
Affiliation(s)
- S Gerber
- Stanford Institute for Materials and Energy Sciences, SLAC National Accelerator Laboratory and Stanford University, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - K W Kim
- Department of Physics, Chungbuk National University, 52 Naesudong-ro, Heungdeok-gu, Cheongju 361-763, Korea
| | - Y Zhang
- Stanford Institute for Materials and Energy Sciences, SLAC National Accelerator Laboratory and Stanford University, 2575 Sand Hill Road, Menlo Park, California 94025, USA.,Advanced Light Source, Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, California 94720, USA
| | - D Zhu
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - N Plonka
- Stanford Institute for Materials and Energy Sciences, SLAC National Accelerator Laboratory and Stanford University, 2575 Sand Hill Road, Menlo Park, California 94025, USA.,Departments of Physics and Applied Physics, Stanford University, 476 Lomita Mall, Stanford, California 94305, USA
| | - M Yi
- Stanford Institute for Materials and Energy Sciences, SLAC National Accelerator Laboratory and Stanford University, 2575 Sand Hill Road, Menlo Park, California 94025, USA.,Departments of Physics and Applied Physics, Stanford University, 476 Lomita Mall, Stanford, California 94305, USA
| | - G L Dakovski
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - D Leuenberger
- Stanford Institute for Materials and Energy Sciences, SLAC National Accelerator Laboratory and Stanford University, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - P S Kirchmann
- Stanford Institute for Materials and Energy Sciences, SLAC National Accelerator Laboratory and Stanford University, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - R G Moore
- Stanford Institute for Materials and Energy Sciences, SLAC National Accelerator Laboratory and Stanford University, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - M Chollet
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - J M Glownia
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - Y Feng
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - J-S Lee
- Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - A Mehta
- Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - A F Kemper
- Computational Research Division, Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, California 94720, USA
| | - T Wolf
- Institute for Solid State Physics, Karlsruhe Institute of Technology, Hermann-v.-Helmholtz-Platz 1, 76021 Karlsruhe, Germany
| | - Y-D Chuang
- Advanced Light Source, Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, California 94720, USA
| | - Z Hussain
- Advanced Light Source, Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, California 94720, USA
| | - C-C Kao
- SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - B Moritz
- Stanford Institute for Materials and Energy Sciences, SLAC National Accelerator Laboratory and Stanford University, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - Z-X Shen
- Stanford Institute for Materials and Energy Sciences, SLAC National Accelerator Laboratory and Stanford University, 2575 Sand Hill Road, Menlo Park, California 94025, USA.,Departments of Physics and Applied Physics, Stanford University, 476 Lomita Mall, Stanford, California 94305, USA
| | - T P Devereaux
- Stanford Institute for Materials and Energy Sciences, SLAC National Accelerator Laboratory and Stanford University, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - W-S Lee
- Stanford Institute for Materials and Energy Sciences, SLAC National Accelerator Laboratory and Stanford University, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| |
Collapse
|
170
|
Zhu D, Cai G, Wu D, Lu J. Comparison of two codon optimization strategies enhancing recombinant Sus scrofa lysozyme production in Pichia pastoris. Cell Mol Biol (Noisy-le-grand) 2015; 61:43-49. [PMID: 26025401] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2015] [Accepted: 05/08/2015] [Indexed: 06/04/2023]
Abstract
Lysozyme has played an important role in animal feed additive industry, food additive industry and biological engineering. For improving expression efficiency of recombinant lysozyme from Sus scrofa, two genes respectively designed by the most used codon optimization strategies, "one amino acid one codon" and "codon randomization", were synthesized and expressed in Pichia pastoris X—33. At shaking flask level, Sus scrofa lysozyme (SSL) under two conditions had a highest activity of 153.33±10.41 and 538.33±15.18 U/mL after a 5 days induction of 1% methanol, with secreted protein concentration 80.03±1.94 and 239.60±4.16 mg/L, respectively. Compared with the original SSL gene, the expression of optimized SSL gene by the second strategy showed a 2.6 fold higher level, while the first method had no obvious improvement in production. In total secreted protein, the proportions of recombinant SSL encoded by the original gene, first method optimized gene and the second—strategy optimized one were 75.06±0.25%, 74.56±0.14% and 79.00±0.14%, respectively, with the same molecular weight about 18 kDa, optimum acidity pH 6.0 and optimum temperature 35degC.
Collapse
Affiliation(s)
- D Zhu
- Ministry of Education, School of Biotechnology, Jiangnan University The Key Laboratory of Industrial Biotechnology Wuxi China
| | - G Cai
- Jiangnan University National Engineering Laboratory for Cereal Fermentation Technology Wuxi China
| | - D Wu
- Jiangnan University National Engineering Laboratory for Cereal Fermentation Technology Wuxi China
| | - J Lu
- Ministry of Education, School of Biotechnology, Jiangnan University The Key Laboratory of Industrial Biotechnology Wuxi China jlu@jiangnan.edu.cn
| |
Collapse
|
171
|
Li A, Wang J, Zhu D, Zhang X, Pan R, Wang R. Arctigenin suppresses transforming growth factor-β1-induced expression of monocyte chemoattractant protein-1 and the subsequent epithelial–mesenchymal transition through reactive oxygen species-dependent ERK/NF-κB signaling pathway in renal tubular epithelial cells. Free Radic Res 2015; 49:1095-113. [DOI: 10.3109/10715762.2015.1038258] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
|
172
|
Bailes J, Bravo S, Breiter H, Kaufman D, Lu Z, Molfese D, Perrish T, Slobounov S, Talavage T, Zhu D. A call to arms: the need to create an inter-institutional concussion neuroimaging consortium to discover clinically relevant diagnostic biomarkers and develop evidence-based interventions to facilitate recovery. Dev Neuropsychol 2015; 40:59-62. [PMID: 25961586 DOI: 10.1080/87565641.2015.1018090] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Affiliation(s)
- J Bailes
- a University of Chicago Pritzker School of Medicine , Chicago , Illinois
| | | | | | | | | | | | | | | | | | | |
Collapse
|
173
|
Feng Y, Alonso-Mori R, Barends TRM, Blank VD, Botha S, Chollet M, Damiani DS, Doak RB, Glownia JM, Koglin JM, Lemke HT, Messerschmidt M, Nass K, Nelson S, Schlichting I, Shoeman RL, Shvyd’ko YV, Sikorski M, Song S, Stoupin S, Terentyev S, Williams GJ, Zhu D, Robert A, Boutet S. Demonstration of simultaneous experiments using thin crystal multiplexing at the Linac Coherent Light Source. J Synchrotron Radiat 2015; 22:626-33. [PMID: 25931078 PMCID: PMC4416679 DOI: 10.1107/s1600577515003999] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/11/2014] [Accepted: 02/26/2015] [Indexed: 05/06/2023]
Abstract
Multiplexing of the Linac Coherent Light Source beam was demonstrated for hard X-rays by spectral division using a near-perfect diamond thin-crystal monochromator operating in the Bragg geometry. The wavefront and coherence properties of both the reflected and transmitted beams were well preserved, thus allowing simultaneous measurements at two separate instruments. In this report, the structure determination of a prototypical protein was performed using serial femtosecond crystallography simultaneously with a femtosecond time-resolved XANES studies of photoexcited spin transition dynamics in an iron spin-crossover system. The results of both experiments using the multiplexed beams are similar to those obtained separately, using a dedicated beam, with no significant differences in quality.
Collapse
Affiliation(s)
- Y. Feng
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, CA 94025, USA
| | - R. Alonso-Mori
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, CA 94025, USA
| | | | - V. D. Blank
- Technological Institute for Superhard and Novel Carbon Materials, Troitsk, Russia
| | - S. Botha
- Max-Planck Institute for Medical Research, Heidelberg, Germany
| | - M. Chollet
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, CA 94025, USA
| | - D. S. Damiani
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, CA 94025, USA
| | - R. B. Doak
- Max-Planck Institute for Medical Research, Heidelberg, Germany
| | - J. M. Glownia
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, CA 94025, USA
| | - J. M. Koglin
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, CA 94025, USA
| | - H. T. Lemke
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, CA 94025, USA
| | - M. Messerschmidt
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, CA 94025, USA
| | - K. Nass
- Max-Planck Institute for Medical Research, Heidelberg, Germany
| | - S. Nelson
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, CA 94025, USA
| | - I. Schlichting
- Max-Planck Institute for Medical Research, Heidelberg, Germany
| | - R. L. Shoeman
- Max-Planck Institute for Medical Research, Heidelberg, Germany
| | - Yu. V. Shvyd’ko
- Advanced Photon Source, Argonne National Laboratory, 9700 South Cass Avenue, Argonne, IL 60439, USA
| | - M. Sikorski
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, CA 94025, USA
| | - S. Song
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, CA 94025, USA
| | - S. Stoupin
- Advanced Photon Source, Argonne National Laboratory, 9700 South Cass Avenue, Argonne, IL 60439, USA
| | - S. Terentyev
- Technological Institute for Superhard and Novel Carbon Materials, Troitsk, Russia
| | - G. J. Williams
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, CA 94025, USA
| | - D. Zhu
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, CA 94025, USA
| | - A. Robert
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, CA 94025, USA
| | - S. Boutet
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, CA 94025, USA
| |
Collapse
|
174
|
Li L, Li T, Zhang Y, Pan Z, Wu B, Huang X, Zhang Y, Mei Y, Ge L, Shen G, Ge RS, Zhu D, Lou Y. Peroxisome proliferator-activated receptorβ/δ activation is essential for modulating p-Foxo1/Foxo1 status in functional insulin-positive cell differentiation. Cell Death Dis 2015; 6:e1715. [PMID: 25855963 PMCID: PMC4650555 DOI: 10.1038/cddis.2015.88] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2014] [Revised: 02/26/2015] [Accepted: 03/02/2015] [Indexed: 11/25/2022]
Abstract
Peroxisome proliferator-activated receptors (PPARs) participate in energy homeostasis and play essential roles in diabetes therapy through their effects on non-pancreas tissues. Pathological microenvironment may influence the metabolic requirements for the maintenance of stem cell differentiation. Accordingly, understanding the mechanisms of PPARs on pancreatic β-cell differentiation may be helpful to find the underlying targets of disrupted energy homeostasis under the pancreatic disease condition. PPARs are involved in stem cell differentiation via mitochondrial oxidative phosphorylation, but the subtype member activation and the downstream regulation in functional insulin-positive (INS+) cell differentiation remain unclear. Here, we show a novel role of PPARβ/δ activation in determining INS+ cell differentiation and functional maturation. We found PPARβ/δ expression selectively upregulated in mouse embryonic pancreases or stem cells-derived INS+ cells at the pancreatic mature stage in vivo and in vitro. Strikingly, given the inefficiency of generating INS+ cells in vitro, PPARβ/δ activation displayed increasing mouse and human ES cell-derived INS+ cell numbers and insulin secretion. This phenomenon was closely associated with the forkhead box protein O1 (Foxo1) nuclear shuttling, which was dependent on PPARβ/δ downstream PI3K/Akt signaling transduction. The present study reveals the essential role of PPARβ/δ activation on p-Foxo1/Foxo1 status, and in turn, determining INS+ cell generation and insulin secretion via affecting pancreatic and duodenal homeobox-1 expression. The results demonstrate the underlying mechanism by which PPARβ/δ activation promotes functional INS+ cell differentiation. It also provides potential targets for anti-diabetes drug discovery and hopeful clinical applications in human cell therapy.
Collapse
Affiliation(s)
- L Li
- Institute of Pharmacology, Toxicology and Biochemical Pharmaceutics, Key Innovation Team for Stem Cell Translational Medicine of Cardiovascular Disease of Zhejiang Province, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
| | - T Li
- Institute of Pharmacology, Toxicology and Biochemical Pharmaceutics, Key Innovation Team for Stem Cell Translational Medicine of Cardiovascular Disease of Zhejiang Province, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
| | - Y Zhang
- Institute of Pharmacology, Toxicology and Biochemical Pharmaceutics, Key Innovation Team for Stem Cell Translational Medicine of Cardiovascular Disease of Zhejiang Province, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
| | - Z Pan
- Institute of Pharmacology, Toxicology and Biochemical Pharmaceutics, Key Innovation Team for Stem Cell Translational Medicine of Cardiovascular Disease of Zhejiang Province, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
| | - B Wu
- Institute of Pharmacology, Toxicology and Biochemical Pharmaceutics, Key Innovation Team for Stem Cell Translational Medicine of Cardiovascular Disease of Zhejiang Province, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
| | - X Huang
- Cardiovascular Key Laboratory of Zhejiang Province, The 2nd Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
| | - Y Zhang
- Institute of Pharmacology, Toxicology and Biochemical Pharmaceutics, Key Innovation Team for Stem Cell Translational Medicine of Cardiovascular Disease of Zhejiang Province, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
| | - Y Mei
- Institute of Pharmacology, Toxicology and Biochemical Pharmaceutics, Key Innovation Team for Stem Cell Translational Medicine of Cardiovascular Disease of Zhejiang Province, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
| | - L Ge
- Institute of Pharmacology, Toxicology and Biochemical Pharmaceutics, Key Innovation Team for Stem Cell Translational Medicine of Cardiovascular Disease of Zhejiang Province, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
| | - G Shen
- Institute of Pharmacology, Toxicology and Biochemical Pharmaceutics, Key Innovation Team for Stem Cell Translational Medicine of Cardiovascular Disease of Zhejiang Province, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
| | - R-s Ge
- 1] The Population Council at the Rockefeller University, New York, NY 10021, USA [2] Institute of Reproductive Biomedicine, the 2nd Affiliated Hospital, Wenzhou Medical University, Wenzhou, China
| | - D Zhu
- Institute of Pharmacology, Toxicology and Biochemical Pharmaceutics, Key Innovation Team for Stem Cell Translational Medicine of Cardiovascular Disease of Zhejiang Province, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
| | - Y Lou
- Institute of Pharmacology, Toxicology and Biochemical Pharmaceutics, Key Innovation Team for Stem Cell Translational Medicine of Cardiovascular Disease of Zhejiang Province, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
| |
Collapse
|
175
|
Trindade AJ, Guilhabert B, Xie EY, Ferreira R, McKendry JJD, Zhu D, Laurand N, Gu E, Wallis DJ, Watson IM, Humphreys CJ, Dawson MD. Heterogeneous integration of gallium nitride light-emitting diodes on diamond and silica by transfer printing. Opt Express 2015; 23:9329-9338. [PMID: 25968763 DOI: 10.1364/oe.23.009329] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
We report the transfer printing of blue-emitting micron-scale light-emitting diodes (micro-LEDs) onto fused silica and diamond substrates without the use of intermediary adhesion layers. A consistent Van der Waals bond was achieved via liquid capillary action, despite curvature of the LED membranes following release from their native silicon growth substrates. The excellence of diamond as a heat-spreader allowed the printed membrane LEDs to achieve optical power output density of 10 W/cm(2) when operated at a current density of 254 A/cm(2). This high-current-density operation enabled optical data transmission from the LEDs at 400 Mbit/s.
Collapse
|
176
|
Zhan L, Jahanshad N, Faskowitz J, Zhu D, Prasad G, Martin NG, de Zubicaray GI, McMahon KL, Wright MJ, Thompson PM. HERITABILITY OF BRAIN NETWORK TOPOLOGY IN 853 TWINS AND SIBLINGS. Proc IEEE Int Symp Biomed Imaging 2015; 2015:449-453. [PMID: 26413204 PMCID: PMC4578220 DOI: 10.1109/isbi.2015.7163908] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Anatomical brain networks change throughout life and with diseases. Genetic analysis of these networks may help identify processes giving rise to heritable brain disorders, but we do not yet know which network measures are promising for genetic analyses. Many factors affect the downstream results, such as the tractography algorithm used to define structural connectivity. We tested nine different tractography algorithms and four normalization methods to compute brain networks for 853 young healthy adults (twins and their siblings). We fitted genetic structural equation models to all nine network measures, after a normalization step to increase network consistency across tractography algorithms. Probabilistic tractography algorithms with global optimization (such as Probtrackx and Hough) yielded higher heritability statistics than "greedy" algorithms (such as FACT) which process small neighborhoods at each step. Some global network measures (probtrackx-derived GLOB and ST) showed significant genetic effects, making them attractive targets for genome-wide association studies.
Collapse
Affiliation(s)
- L Zhan
- Dept. of Neurology, University of California, Los Angeles, CA 90095, USA ; Imaging Genetics Center, Keck School of Medicine, University of Southern California, Marina Del Rey, CA 90292, USA
| | - N Jahanshad
- Imaging Genetics Center, Keck School of Medicine, University of Southern California, Marina Del Rey, CA 90292, USA
| | - J Faskowitz
- Imaging Genetics Center, Keck School of Medicine, University of Southern California, Marina Del Rey, CA 90292, USA
| | - D Zhu
- Imaging Genetics Center, Keck School of Medicine, University of Southern California, Marina Del Rey, CA 90292, USA
| | - G Prasad
- Imaging Genetics Center, Keck School of Medicine, University of Southern California, Marina Del Rey, CA 90292, USA
| | - N G Martin
- QIMR Berghofer Medical Research Institute, Brisbane, QLD 4029, Australia
| | - G I de Zubicaray
- School of Psychology, University of Queensland, Brisbane, QLD 4072, Australia
| | - K L McMahon
- Centre for Advanced Imaging, University of Queensland, Brisbane, QLD 4072, Australia
| | - M J Wright
- QIMR Berghofer Medical Research Institute, Brisbane, QLD 4029, Australia
| | - P M Thompson
- Imaging Genetics Center, Keck School of Medicine, University of Southern California, Marina Del Rey, CA 90292, USA
| |
Collapse
|
177
|
Zhang F, Zhu D, Xie L, Guo X, Ni Y, Sun J. Molecular epidemiology of carbapenemase-producing Escherichia coli and the prevalence of ST131 subclone H30 in Shanghai, China. Eur J Clin Microbiol Infect Dis 2015; 34:1263-9. [PMID: 25759112 DOI: 10.1007/s10096-015-2356-3] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2015] [Accepted: 02/23/2015] [Indexed: 11/29/2022]
Abstract
The molecular characteristics and epidemiology of carbapenemase-producing Escherichia coli (CPEC) isolates from Shanghai, China, were investigated using 21 imipenem-resistant E. coli isolates obtained from a Shanghai teaching hospital from 2011 to 2014. The presence of bla KPC, bla IMP, bla VIM, bla OXA-48, and bla NDM was assessed by polymerase chain reaction (PCR) amplification and sequencing. CPEC isolates were characterized by the Etest®, multilocus sequence typing (MLST), and pulse-field gel electrophoresis (PFGE). Plasmids carrying resistance genes were analyzed by conjugation experiments, replicon typing, plasmid MLST (pMLST), S1 nuclease PFGE (S1-PFGE), and Southern hybridization. The genetic environment of the resistance genes was determined by PCR and sequencing. Among the 21 E. coli isolates, 16 produced carbapenemases; of these, ten isolates transferred carbapenemase-encoding plasmids to recipient bacteria. Nine of the 16 isolates were clonally related, and their PFGE patterns were designated type A. ST131 was the predominant sequence type (11 isolates, 68.8 %); the H30 subclone comprised 81.8 % of the ST131 strains. In all three isolates, bla IMP-4 was located on 50-kb IncN plasmids. All but two bla KPC-2 genes were carried on IncF plasmids of various sizes. Hence, both clone-spread and horizontal transfer mediated the dissemination of carbapenemase-producing genes in the Shanghai isolates.
Collapse
Affiliation(s)
- F Zhang
- Department of Clinical Microbiology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, 197 Ruijin No. 2 Road, Shanghai, 200025, China
| | | | | | | | | | | |
Collapse
|
178
|
Wang Y, Zhao N, Qiu J, He X, Zhou M, Cui H, Lv L, Lin X, Zhang C, Zhang H, Xu R, Zhu D, Dang Y, Han X, Zhang H, Bai H, Chen Y, Tang Z, Lin R, Yao T, Su J, Xu X, Liu X, Wang W, Ma B, Liu S, Qiu W, Huang H, Liang J, Wang S, Ehrenkranz RA, Kim C, Liu Q, Zhang Y. Folic acid supplementation and dietary folate intake, and risk of preeclampsia. Eur J Clin Nutr 2015; 69:1145-1150. [PMID: 25626412 DOI: 10.1038/ejcn.2014.295] [Citation(s) in RCA: 40] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2014] [Revised: 11/18/2014] [Accepted: 12/10/2014] [Indexed: 11/09/2022]
Abstract
BACKGROUND/OBJECTIVES Folic acid supplementation has been suggested to reduce the risk of preeclampsia. However, results from few epidemiologic studies have been inconclusive. We investigated the hypothesis that folic acid supplementation and dietary folate intake before conception and during pregnancy reduce the risk of preeclampsia. SUBJECTS/METHODS A birth cohort study was conducted in 2010-2012 at the Gansu Provincial Maternity & Child Care Hospital in Lanzhou, China. A total of 10,041 pregnant women without chronic hypertension or gestational hypertension were enrolled. RESULTS Compared with nonusers, folic acid supplement users had a reduced risk of preeclampsia (OR=0.61, 95% CI: 0.43-0.87). A significant dose-response of duration of use was observed among women who used folic acid supplemention during pregnancy only (P-trend=0.007). The reduced risk associated with folic acid supplement was similar for mild or severe preeclampsia and for early- or late-onset preeclampsia, although the statistical significant associations were only observed for mild (OR=0.50, 95% CI: 0.30-0.81) and late-onset (OR=0.60, 95% CI: 0.42-0.86) preeclampsia. The reduced risk associated with dietary folate intake during pregnancy was only seen for severe preeclampsia (OR=0.52, 95% CI: 0.31-0.87, for the highest quartile of dietary folate intake compared with the lowest). CONCLUSIONS Our study results suggest that folic acid supplementation and higher dietary folate intake during pregnancy reduce the risk of preeclampsia. Future studies are needed to confirm the associations.
Collapse
Affiliation(s)
- Y Wang
- Gansu Provincial Maternity and Child Care Hospital, Lanzhou, Gansu, China
| | - N Zhao
- Department of Environmental Health Sciences, School of Public Health, Yale University, New Haven, CT, USA
| | - J Qiu
- Gansu Provincial Maternity and Child Care Hospital, Lanzhou, Gansu, China
| | - X He
- Gansu Provincial Maternity and Child Care Hospital, Lanzhou, Gansu, China
| | - M Zhou
- Gansu Provincial Maternity and Child Care Hospital, Lanzhou, Gansu, China
| | - H Cui
- Gansu Provincial Maternity and Child Care Hospital, Lanzhou, Gansu, China
| | - L Lv
- Gansu Provincial Maternity and Child Care Hospital, Lanzhou, Gansu, China
| | - X Lin
- Gansu Provincial Maternity and Child Care Hospital, Lanzhou, Gansu, China
| | - C Zhang
- Gansu Provincial Maternity and Child Care Hospital, Lanzhou, Gansu, China
| | - H Zhang
- Gansu Provincial Maternity and Child Care Hospital, Lanzhou, Gansu, China
| | - R Xu
- Gansu Provincial Maternity and Child Care Hospital, Lanzhou, Gansu, China
| | - D Zhu
- Gansu Provincial Maternity and Child Care Hospital, Lanzhou, Gansu, China
| | - Y Dang
- Gansu Provincial Maternity and Child Care Hospital, Lanzhou, Gansu, China
| | - X Han
- Gansu Provincial Maternity and Child Care Hospital, Lanzhou, Gansu, China
| | - H Zhang
- Gansu Provincial Maternity and Child Care Hospital, Lanzhou, Gansu, China
| | - H Bai
- Gansu Provincial Maternity and Child Care Hospital, Lanzhou, Gansu, China
| | - Y Chen
- Gansu Provincial Maternity and Child Care Hospital, Lanzhou, Gansu, China
| | - Z Tang
- Gansu Provincial Maternity and Child Care Hospital, Lanzhou, Gansu, China
| | - R Lin
- Gansu Provincial Maternity and Child Care Hospital, Lanzhou, Gansu, China
| | - T Yao
- Gansu Provincial Maternity and Child Care Hospital, Lanzhou, Gansu, China
| | - J Su
- Gansu Provincial Maternity and Child Care Hospital, Lanzhou, Gansu, China
| | - X Xu
- Gansu Provincial Maternity and Child Care Hospital, Lanzhou, Gansu, China
| | - X Liu
- Gansu Provincial Maternity and Child Care Hospital, Lanzhou, Gansu, China
| | - W Wang
- Gansu Provincial Maternity and Child Care Hospital, Lanzhou, Gansu, China
| | - B Ma
- Gansu Provincial Maternity and Child Care Hospital, Lanzhou, Gansu, China
| | - S Liu
- Gansu Provincial Maternity and Child Care Hospital, Lanzhou, Gansu, China
| | - W Qiu
- Gansu Provincial Maternity and Child Care Hospital, Lanzhou, Gansu, China
| | - H Huang
- Department of Environmental Health Sciences, School of Public Health, Yale University, New Haven, CT, USA
| | - J Liang
- Department of Environmental Health Sciences, School of Public Health, Yale University, New Haven, CT, USA
| | - S Wang
- Department of Epidemiology, School of Public Health, Shanxi Medical University, Taiyuan, Shanxi, China
| | - R A Ehrenkranz
- Department of Pediatrics, School of Medicine, Yale University, New Haven, CT, USA
| | - C Kim
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Sciences, Bethesda, MD, USA
| | - Q Liu
- Gansu Provincial Maternity and Child Care Hospital, Lanzhou, Gansu, China
| | - Y Zhang
- Department of Environmental Health Sciences, School of Public Health, Yale University, New Haven, CT, USA
| |
Collapse
|
179
|
Zhang YQ, Zhu D, Zhou XY, Liu YY, Qin B, Ren GP, Xie P. Bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis of randomized controlled trials. ACTA ACUST UNITED AC 2015; 48:198-206. [PMID: 25590350 PMCID: PMC4381939 DOI: 10.1590/1414-431x20144270] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2014] [Accepted: 09/09/2014] [Indexed: 01/30/2023]
Abstract
There has been concern regarding the use of controversial paradigms for repetitive
transcranial magnetic stimulation (rTMS) to manage treatment-resistant depression
(TRD). This meta-analysis assessed the efficacy of bilateral rTMS compared with
unilateral and sham rTMS in patients with TRD. PubMed, Embase, CENTRAL, PsycINFO, Web
of Science, EAGLE and NTIS databases were searched to identify relevant studies, and
randomized controlled trials (RCTs) on bilateral rTMS for TRD patients were included.
The response was defined as the primary outcome, and remission was the secondary
outcome. Ten RCTs that included 634 patients met the eligibility criteria. The risk
ratio (RRs) of both the primary and secondary outcomes of bilateral rTMS showed
non-significant increases compared to unilateral rTMS (RR=1.01, P=0.93; odds ratio
[OR]=0.77, P=0.22). Notably, the RR of the primary bilateral rTMS outcome was
significantly increased compared to that for sham rTMS (RR=3.43, P=0.0004). The
results of our analysis demonstrated that bilateral rTMS was significantly more
effective than sham rTMS but not unilateral rTMS in patients with TRD. Thus,
bilateral rTMS may not be a useful paradigm for patients with TRD.
Collapse
Affiliation(s)
- Y Q Zhang
- Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
| | - D Zhu
- Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
| | - X Y Zhou
- Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
| | - Y Y Liu
- Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
| | - B Qin
- Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
| | - G P Ren
- Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
| | - P Xie
- Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
| |
Collapse
|
180
|
Lutman AA, Decker FJ, Arthur J, Chollet M, Feng Y, Hastings J, Huang Z, Lemke H, Nuhn HD, Marinelli A, Turner JL, Wakatsuki S, Welch J, Zhu D. Demonstration of single-crystal self-seeded two-color x-ray free-electron lasers. Phys Rev Lett 2014; 113:254801. [PMID: 25554887 DOI: 10.1103/physrevlett.113.254801] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/12/2014] [Indexed: 05/24/2023]
Abstract
A scheme for generating two simultaneous hard-x-ray free-electron laser pulses with a controllable difference in photon energy is described and then demonstrated using the self-seeding setup at the Linac Coherent Light Source (LCLS). The scheme takes advantage of the existing LCLS equipment, which allows two independent rotations of the self-seeding diamond crystal. The two degrees of freedom are used to select two nearby crystal reflections, causing two wavelengths to be present in the forward transmitted seeding x-ray pulse. The free-electron laser system must support amplification at both desired wavelengths.
Collapse
Affiliation(s)
- A A Lutman
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - F-J Decker
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - J Arthur
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - M Chollet
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - Y Feng
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - J Hastings
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - Z Huang
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - H Lemke
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - H-D Nuhn
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - A Marinelli
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - J L Turner
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - S Wakatsuki
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - J Welch
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - D Zhu
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| |
Collapse
|
181
|
Almusallam A, Yang K, Cao Z, Zhu D, Tudor J, Beeby SP. Improving the dielectric and piezoelectric properties of screen-printed Low temperature PZT/polymer composite using cold isostatic pressing. ACTA ACUST UNITED AC 2014. [DOI: 10.1088/1742-6596/557/1/012083] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
182
|
|
183
|
Sattiraju A, Birbrair A, Zhu D, Batista I, Delbono O, Mintz A. SC-29 * THERAPEUTIC POTENTIAL OF A NEWLY DISCOVERED NEURAL LIKE STEM CELL. Neuro Oncol 2014. [DOI: 10.1093/neuonc/nou275.29] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
184
|
|
185
|
Beaud P, Caviezel A, Mariager SO, Rettig L, Ingold G, Dornes C, Huang SW, Johnson JA, Radovic M, Huber T, Kubacka T, Ferrer A, Lemke HT, Chollet M, Zhu D, Glownia JM, Sikorski M, Robert A, Wadati H, Nakamura M, Kawasaki M, Tokura Y, Johnson SL, Staub U. A time-dependent order parameter for ultrafast photoinduced phase transitions. Nat Mater 2014; 13:923-7. [PMID: 25087068 DOI: 10.1038/nmat4046] [Citation(s) in RCA: 89] [Impact Index Per Article: 8.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/10/2014] [Accepted: 07/01/2014] [Indexed: 05/06/2023]
Abstract
Strongly correlated electron systems often exhibit very strong interactions between structural and electronic degrees of freedom that lead to complex and interesting phase diagrams. For technological applications of these materials it is important to learn how to drive transitions from one phase to another. A key question here is the ultimate speed of such phase transitions, and to understand how a phase transition evolves in the time domain. Here we apply time-resolved X-ray diffraction to directly measure the changes in long-range order during ultrafast melting of the charge and orbitally ordered phase in a perovskite manganite. We find that although the actual change in crystal symmetry associated with this transition occurs over different timescales characteristic of the many electronic and vibrational coordinates of the system, the dynamics of the phase transformation can be well described using a single time-dependent 'order parameter' that depends exclusively on the electronic excitation.
Collapse
Affiliation(s)
- P Beaud
- 1] Swiss Light Source, Paul Scherrer Institut, 5232 Villigen PSI, Switzerland [2] SwissFEL, Paul Scherrer Institut, 5232 Villigen PSI, Switzerland
| | - A Caviezel
- Swiss Light Source, Paul Scherrer Institut, 5232 Villigen PSI, Switzerland
| | - S O Mariager
- Swiss Light Source, Paul Scherrer Institut, 5232 Villigen PSI, Switzerland
| | - L Rettig
- Swiss Light Source, Paul Scherrer Institut, 5232 Villigen PSI, Switzerland
| | - G Ingold
- 1] Swiss Light Source, Paul Scherrer Institut, 5232 Villigen PSI, Switzerland [2] SwissFEL, Paul Scherrer Institut, 5232 Villigen PSI, Switzerland
| | - C Dornes
- Institute for Quantum Electronics, ETH Zürich, 8093 Zürich, Switzerland
| | - S-W Huang
- Swiss Light Source, Paul Scherrer Institut, 5232 Villigen PSI, Switzerland
| | - J A Johnson
- Swiss Light Source, Paul Scherrer Institut, 5232 Villigen PSI, Switzerland
| | - M Radovic
- 1] Swiss Light Source, Paul Scherrer Institut, 5232 Villigen PSI, Switzerland [2] SwissFEL, Paul Scherrer Institut, 5232 Villigen PSI, Switzerland
| | - T Huber
- Institute for Quantum Electronics, ETH Zürich, 8093 Zürich, Switzerland
| | - T Kubacka
- Institute for Quantum Electronics, ETH Zürich, 8093 Zürich, Switzerland
| | - A Ferrer
- 1] Swiss Light Source, Paul Scherrer Institut, 5232 Villigen PSI, Switzerland [2] Institute for Quantum Electronics, ETH Zürich, 8093 Zürich, Switzerland
| | - H T Lemke
- LCLS, SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - M Chollet
- LCLS, SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - D Zhu
- LCLS, SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - J M Glownia
- LCLS, SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - M Sikorski
- LCLS, SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - A Robert
- LCLS, SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - H Wadati
- 1] Department of Applied Physics and Quantum-Phase Electronics Center, University of Tokyo, Hongo, Tokyo 113-8656, Japan [2] Institute for Solid State Physics, University of Tokyo, Kashiwanoha 5-1-5, Chiba 277-8581, Japan
| | - M Nakamura
- RIKEN Center for Emergent Matter Science (CEMS), Wako 351-0198, Japan
| | - M Kawasaki
- 1] Department of Applied Physics and Quantum-Phase Electronics Center, University of Tokyo, Hongo, Tokyo 113-8656, Japan [2] RIKEN Center for Emergent Matter Science (CEMS), Wako 351-0198, Japan
| | - Y Tokura
- 1] Department of Applied Physics and Quantum-Phase Electronics Center, University of Tokyo, Hongo, Tokyo 113-8656, Japan [2] RIKEN Center for Emergent Matter Science (CEMS), Wako 351-0198, Japan
| | - S L Johnson
- Institute for Quantum Electronics, ETH Zürich, 8093 Zürich, Switzerland
| | - U Staub
- Swiss Light Source, Paul Scherrer Institut, 5232 Villigen PSI, Switzerland
| |
Collapse
|
186
|
Pavlov AN, Semyachkina-Glushkovskaya OV, Zhang Y, Bibikova OA, Pavlova ON, Huang Q, Zhu D, Li P, Tuchin VV, Luo Q. Multiresolution analysis of pathological changes in cerebral venous dynamics in newborn mice with intracranial hemorrhage: adrenorelated vasorelaxation. Physiol Meas 2014; 35:1983-99. [PMID: 25238178 DOI: 10.1088/0967-3334/35/10/1983] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
Intracranial hemorrhage (ICH) is the major problem of modern neonatal intensive care. Abnormalities of cerebral venous blood flow (CVBF) can play a crucial role in the development of ICH in infants. The mechanisms underlying these pathological processes remain unclear; however it has been established that the activation of the adrenorelated vasorelaxation can be an important reason. Aiming to reach a better understanding of how the adrenodependent relaxation of cerebral veins contributes to the development of ICH in newborns, we study here the effects of pharmacological stimulation of adrenorelated dilation of the sagittal sinus by isoproterenol on the cerebral venous hemodynamics. Our study is performed in newborn mice at different stages of ICH using the laser speckle contrast imaging and wavelet analysis of the vascular dynamics of CVBF. We show that the dilation of the sagittal sinus with the decreased velocity of blood flow presides to the stress-induced ICH in newborn mice. These morphofunctional vascular changes are accompanied by an increased variance of the wavelet-coefficients in the areas of endothelial and non-endothelial (KATP-channels activity of vascular muscle) sympathetic components of the CVBF variability. Changes in the cerebral venous hemodynamics at the latent stage of ICH are associated with a high responsiveness of the sagittal sinus to isoproterenol quantifying by wavelet-coefficients related to a very slow region of the frequency domain. The obtained results certify that a high activation of the adrenergic-related vasodilatory responses to severe stress in newborn mice can be one of the important mechanisms underlying the development of ICH. Thus, the venous insufficiency with the decreased blood outflow from the brain associated with changes in the endothelial and the sympathetic components of CVBF-variability can be treated as prognostic criteria for the risk of ICH during the first days after birth.
Collapse
Affiliation(s)
- A N Pavlov
- Department of Physics, Saratov State University, Astrakhanskaya Str. 83, Saratov, 410012, Russia. Saratov State Technical University, Politehnicheskaya Str. 77, Saratov, 410054, Russia. Wuhan National Laboratory for Optoelectronics, Britton Chance Center for Biomedical Photonics, Huazhong University of Science and Technology, Wuhan 430074, People's Republic of China
| | | | | | | | | | | | | | | | | | | |
Collapse
|
187
|
Xu C, Shi L, Rao S, King C, Sun H, Zhu D, Lehto S, Wild K, Immke D. EHMTI-0315. AMG 334, the first potent and selective human monoclonal antibody antagonist against the CGRP receptor. J Headache Pain 2014. [PMCID: PMC4182181 DOI: 10.1186/1129-2377-15-s1-g43] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
188
|
Bionta MR, Hartmann N, Weaver M, French D, Nicholson DJ, Cryan JP, Glownia JM, Baker K, Bostedt C, Chollet M, Ding Y, Fritz DM, Fry AR, Kane DJ, Krzywinski J, Lemke HT, Messerschmidt M, Schorb S, Zhu D, White WE, Coffee RN. Spectral encoding method for measuring the relative arrival time between x-ray/optical pulses. Rev Sci Instrum 2014; 85:083116. [PMID: 25173255 DOI: 10.1063/1.4893657] [Citation(s) in RCA: 37] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/06/2023]
Abstract
The advent of few femtosecond x-ray light sources brings promise of x-ray/optical pump-probe experiments that can measure chemical and structural changes in the 10-100 fs time regime. Widely distributed timing systems used at x-ray Free-Electron Laser facilities are typically limited to above 50 fs fwhm jitter in active x-ray/optical synchronization. The approach of single-shot timing measurements is used to sort results in the event processing stage. This has seen wide use to accommodate the insufficient precision of active stabilization schemes. In this article, we review the current technique for "measure-and-sort" at the Linac Coherent Light Source at the SLAC National Accelerator Laboratory. The relative arrival time between an x-ray pulse and an optical pulse is measured near the experimental interaction region as a spectrally encoded cross-correlation signal. The cross-correlation provides a time-stamp for filter-and-sort algorithms used for real-time sorting. Sub-10 fs rms resolution is common in this technique, placing timing precision at the same scale as the duration of the shortest achievable x-ray pulses.
Collapse
Affiliation(s)
- M R Bionta
- Université de Toulouse, UPS, Laboratoire Collisions Agrégats Réactivité, IRSAMC, F-31062 Toulouse, France
| | - N Hartmann
- The Linac Coherent Light Source, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - M Weaver
- The Linac Coherent Light Source, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - D French
- The Linac Coherent Light Source, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - D J Nicholson
- The Linac Coherent Light Source, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - J P Cryan
- Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, California 94720, USA
| | - J M Glownia
- The Linac Coherent Light Source, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - K Baker
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551, USA
| | - C Bostedt
- The Linac Coherent Light Source, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - M Chollet
- The Linac Coherent Light Source, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - Y Ding
- The Linac Coherent Light Source, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - D M Fritz
- The Linac Coherent Light Source, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - A R Fry
- The Linac Coherent Light Source, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - D J Kane
- Mesa Photonics, LLC., 1550 Pacheco St., Santa Fe, New Mexico 87505, USA
| | - J Krzywinski
- The Linac Coherent Light Source, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - H T Lemke
- The Linac Coherent Light Source, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - M Messerschmidt
- The Linac Coherent Light Source, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - S Schorb
- The Linac Coherent Light Source, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - D Zhu
- The Linac Coherent Light Source, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - W E White
- The Linac Coherent Light Source, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - R N Coffee
- The Linac Coherent Light Source, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| |
Collapse
|
189
|
Stoupin S, Terentyev SA, Blank VD, Shvyd'ko YV, Goetze K, Assoufid L, Polyakov SN, Kuznetsov MS, Kornilov NV, Katsoudas J, Alonso-Mori R, Chollet M, Feng Y, Glownia JM, Lemke H, Robert A, Sikorski M, Song S, Zhu D. All-diamond optical assemblies for a beam-multiplexing X-ray monochromator at the Linac Coherent Light Source. J Appl Crystallogr 2014; 47:1329-1336. [PMID: 25242912 PMCID: PMC4119950 DOI: 10.1107/s1600576714013028] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2014] [Accepted: 06/04/2014] [Indexed: 12/02/2022] Open
Abstract
All-diamond optical assemblies holding state-of-the-art type IIa diamond crystals enable the construction of a beam-multiplexing X-ray double-crystal monochromator for hard X-ray free-electron lasers. Details on the design, fabrication and X-ray diffraction characterization of the assemblies are reported. A double-crystal diamond (111) monochromator recently implemented at the Linac Coherent Light Source (LCLS) enables splitting of the primary X-ray beam into a pink (transmitted) and a monochromatic (reflected) branch. The first monochromator crystal, with a thickness of ∼100 µm, provides sufficient X-ray transmittance to enable simultaneous operation of two beamlines. This article reports the design, fabrication and X-ray characterization of the first and second (300 µm-thick) crystals utilized in the monochromator and the optical assemblies holding these crystals. Each crystal plate has a region of about 5 × 2 mm with low defect concentration, sufficient for use in X-ray optics at the LCLS. The optical assemblies holding the crystals were designed to provide mounting on a rigid substrate and to minimize mounting-induced crystal strain. The induced strain was evaluated using double-crystal X-ray topography and was found to be small over the 5 × 2 mm working regions of the crystals.
Collapse
Affiliation(s)
- S Stoupin
- Advanced Photon Source, Argonne National Laboratory, Argonne, Illinois, USA
| | - S A Terentyev
- Technological Institute for Superhard and Novel Carbon Materials, Troitsk, Russian Federation
| | - V D Blank
- Technological Institute for Superhard and Novel Carbon Materials, Troitsk, Russian Federation
| | - Yu V Shvyd'ko
- Advanced Photon Source, Argonne National Laboratory, Argonne, Illinois, USA
| | - K Goetze
- Advanced Photon Source, Argonne National Laboratory, Argonne, Illinois, USA
| | - L Assoufid
- Advanced Photon Source, Argonne National Laboratory, Argonne, Illinois, USA
| | - S N Polyakov
- Technological Institute for Superhard and Novel Carbon Materials, Troitsk, Russian Federation ; Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, Moscow, Russian Federation
| | - M S Kuznetsov
- Technological Institute for Superhard and Novel Carbon Materials, Troitsk, Russian Federation
| | - N V Kornilov
- Technological Institute for Superhard and Novel Carbon Materials, Troitsk, Russian Federation
| | - J Katsoudas
- Illinois Institute of Technology, Chicago, Illinois, USA
| | - R Alonso-Mori
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, California, USA
| | - M Chollet
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, California, USA
| | - Y Feng
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, California, USA
| | - J M Glownia
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, California, USA
| | - H Lemke
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, California, USA
| | - A Robert
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, California, USA
| | - M Sikorski
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, California, USA
| | - S Song
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, California, USA
| | - D Zhu
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, California, USA
| |
Collapse
|
190
|
Zhu D, Ravindranath MH, Terasaki PI, Miyazaki T, Pham T, Jucaud V. Suppression of allo-human leucocyte antigen (HLA) antibodies secreted by B memory cells in vitro: intravenous immunoglobulin (IVIg) versus a monoclonal anti-HLA-E IgG that mimics HLA-I reactivities of IVIg. Clin Exp Immunol 2014; 177:464-77. [PMID: 24611451 PMCID: PMC4226597 DOI: 10.1111/cei.12307] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/17/2014] [Indexed: 12/20/2022] Open
Abstract
B memory cells remain in circulation and secrete alloantibodies without antigen exposure > 20 years after alloimmunization postpartum or by transplantation. These long-lived B cells are resistant to cytostatic drugs. Therapeutically, intravenous immunoglobulin (IVIg) is administered to reduce allo-human leucocyte antigen (HLA) antibodies pre- and post-transplantation, but the mechanism of reduction remains unclear. Recently, we reported that IVIg reacts with several HLA-I alleles and the HLA reactivity of IVIg is lost after its HLA-E reactivity is adsorbed out. Therefore, we have generated an anti-HLA-E monoclonal antibody that mimics the HLA-reactivity of IVIg to investigate whether this antibody suppresses IgG secretion, as does IVIg. B cells were purified from the blood of a woman in whose blood the B memory cells remained without antigen exposure > 20 years after postpartum alloimmunization. The B cells were stimulated with cytokines using a well-defined culture system. The anti-HLA-E monoclonal antibody (mAb) significantly suppressed the allo-HLA class-II IgG produced by the B cells, and that this suppression was far superior to that by IVIg. These findings were confirmed with HLA-I antibody secreted by the immortalized B cell line, developed from the blood of another alloimmunized woman. The binding affinity of the anti-HLA-E mAb for peptide sequences shared (i.e. shared epitopes) between HLA-E and other β2-microglobulin-free HLA heavy chains (open conformers) on the cell surface of B cells may act as a ligand and signal suppression of IgG production of activated B memory cells. We propose that anti-HLA-E monoclonal antibody may also be useful to suppress allo-HLA IgG production in vivo.
Collapse
Affiliation(s)
- D Zhu
- Terasaki Foundation Laboratory, Los Angeles, CA, USA; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China
| | | | | | | | | | | |
Collapse
|
191
|
Zhu D, Tan Y, Yang X, Qiao J, Yu C, Wang L, Li J, Zhang Z, Zhong L. Phospholipase C gamma 1 is a potential prognostic biomarker for patients with locally advanced and resectable oral squamous cell carcinoma. Int J Oral Maxillofac Surg 2014; 43:1418-26. [PMID: 25085076 DOI: 10.1016/j.ijom.2014.07.001] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2014] [Revised: 05/14/2014] [Accepted: 07/02/2014] [Indexed: 02/06/2023]
Abstract
The aim of this study was to investigate the prognostic and predictive values of phospholipase C gamma 1 (PLCG1) expression in patients with locally advanced and resectable oral squamous cell carcinoma (OSCC), who were treated in a prospective, randomized, phase 3 trial evaluating standard treatment with surgery and postoperative radiation preceded or not by induction docetaxel, cisplatin, and 5-fluorouracil (TPF). Immunohistochemical staining for PLCG1 was performed on the biopsies of 232 out of 256 OSCC patients at clinical stage III/IVA; the PLCG1 positive score was determined by immunoreactive scoring system. The survival analysis was performed by Kaplan-Meier method; hazard ratios were calculated using the Cox proportional hazards model. Patients with a low PLCG1 expression had a significantly better overall survival (P=0.022), and a trend towards better disease-free survival (P=0.087), loco-regional recurrence-free survival (P=0.058), distant metastasis-free survival (P=0.053), and a high response rate to TPF induction chemotherapy with regard to clinical response (P=0.052) and pathological response (P=0.061), compared to those with high PLCG1 expression. Our results suggest that PLCG1 expression could be used as a prognostic biomarker for patients with advanced OSCC; however, it was not an adequate predictive biomarker for TPF induction chemotherapy.
Collapse
Affiliation(s)
- D Zhu
- Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Y Tan
- Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - X Yang
- Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - J Qiao
- Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - C Yu
- Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - L Wang
- Department of Oral Pathology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - J Li
- Department of Oral Pathology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Z Zhang
- Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - L Zhong
- Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
| |
Collapse
|
192
|
Zhu Y, Zheng C, Zhu D, Weber R, Jiang J. P973: H reflex of flexor carpi radialis is affected in C7, not C6 radiculopathies. Clin Neurophysiol 2014. [DOI: 10.1016/s1388-2457(14)51007-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
193
|
Carini GA, Boutet S, Chollet M, Dragone A, Haller G, Hart PA, Herrmann SC, Kenney CJ, Koglin J, Messerschmidt M, Nelson S, Pines J, Robert A, Song S, Thayer JB, Williams GJ, Zhu D. Experience with the CSPAD during dedicated detector runs at LCLS. ACTA ACUST UNITED AC 2014. [DOI: 10.1088/1742-6596/493/1/012011] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
194
|
Lin Z, Wang L, Li M, Zhou D, Zhu D. EP-1109: Is level Ib included as CTV for prophylactic irradiation necessary in negative Ib node NPC patients treated by IMRT? Radiother Oncol 2014. [DOI: 10.1016/s0167-8140(15)31227-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
195
|
Zhuang M, Zhu D, Huang L, Peng X, Qiu Q, Wu R, Lin Z, Chen Z. EP-1609: Volumetric modulated arcs with flattening filter-free beams for recurrent nasopharyngeal carcinoma. Radiother Oncol 2014. [DOI: 10.1016/s0167-8140(15)31727-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
196
|
Hamers RJ, Bandy JA, Zhu D, Zhang L. Photoemission from diamond films and substrates into water: dynamics of solvated electrons and implications for diamond photoelectrochemistry. Faraday Discuss 2014; 172:397-411. [DOI: 10.1039/c4fd00039k] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Abstract
Illumination of diamond with above-bandgap light results in emission of electrons into water and formation of solvated electrons. Here we characterize the materials factors that affect that dynamics of the solvated electrons produced by illumination of niobium substrates and of diamond thin films grown on niobium substrates using transient absorption spectroscopy, and we relate the solvated electron dynamics to the ability to reduce N2 to NH3. For diamond films grown on niobium substrates for different lengths of time, the initial yield of electrons is similar for the different samples, but the lifetime of the solvated electrons increases approximately 10-fold as the film grows. The time-averaged solvated electron concentration and the yield of NH3 produced from N2 both show maxima for films grown for 1–2 hours, with thicknesses of 100–200 nm. Measurements at different values of pH on boron-doped diamond films show that the instantaneous electron emission is nearly independent of pH, but the solvated electron lifetime becomes longer as the pH is increased from pH = 2 to pH = 5. Finally, we also illustrate an important caveat arising from the fact that charge neutrality requires that light-induced emission of electrons from diamond must be accompanied by corresponding oxidation reactions. In situations where the valence band holes cannot readily induce solution-phase oxidation reactions, the diamond itself can be etched by reacting with water to produce CO. Implications for other reactions such as photocatalytic CO2 reduction are discussed, along with strategies for mitigating the potential photo-etching phenomena.
Collapse
Affiliation(s)
- R. J. Hamers
- Dept. of Chemistry
- University of Wisconsin-Madison
- Madison, USA
| | - J. A. Bandy
- Dept. of Chemistry
- University of Wisconsin-Madison
- Madison, USA
| | - D. Zhu
- Dept. of Chemistry
- University of Wisconsin-Madison
- Madison, USA
| | - L. Zhang
- Dept. of Chemistry
- University of Wisconsin-Madison
- Madison, USA
| |
Collapse
|
197
|
Almusallam A, Torah RN, Zhu D, Tudor MJ, Beeby SP. Screen-printed piezoelectric shoe-insole energy harvester using an improved flexible PZT-polymer composites. ACTA ACUST UNITED AC 2013. [DOI: 10.1088/1742-6596/476/1/012108] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
198
|
|
199
|
Ye L, Zhong Y, Wei Y, Li R, Zhu D, Lin Q, Chang W, Chen J, Qin X, Xu J. Early Tumor Shrinkage as Predictor of Outcome in Colorectal Liver Metastases Treated with Cetuximab Plus Chemotherapy. Ann Oncol 2013. [DOI: 10.1093/annonc/mdt443.2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
200
|
Agarwal M, Nitta R, Dovat S, Li G, Arita H, Narita Y, Fukushima S, Tateishi K, Matsushita Y, Yoshida A, Miyakita Y, Ohno M, Collins VP, Kawahara N, Shibui S, Ichimura K, Kahn SA, Gholamin S, Junier MP, Chneiweiss H, Weissman I, Mitra S, Cheshier S, Avril T, Hamlat A, Le Reste PJ, Mosser J, Quillien V, Carrato C, Munoz-Marmol A, Serrano L, Pijuan L, Hostalot C, Villa SL, Ariza A, Etxaniz O, Balana C, Benveniste ET, Zheng Y, McFarland B, Drygin D, Bellis S, Bredel M, Lotsch D, Engelmaier C, Allerstorfer S, Grusch M, Pichler J, Weis S, Hainfellner J, Marosi C, Spiegl-Kreinecker S, Berger W, Bronisz A, Nowicki MO, Wang Y, Ansari K, Chiocca EA, Godlewski J, Brown K, Kwatra M, Brown K, Kwatra M, Bui T, Nitta R, Li G, Zhu S, Kozono D, Li J, Kushwaha D, Carter B, Chen C, Schulte J, Srikanth M, Das S, Zhang J, Lathia J, Yin L, Rich J, Olson E, Kessler J, Chenn A, Cherry A, Haas B, Lin YH, Ong SE, Stella N, Cifarelli CP, Griffin RJ, Cong D, Zhu W, Shi Y, Clark P, Kuo J, Hu S, Sun D, Bookland M, Darbinian N, Dey A, Robitaille M, Remke M, Faury D, Maier C, Malhotra A, Jabado N, Taylor M, Angers S, Kenney A, Ren X, Zhou H, Schur M, Baweja A, Singh M, Erdreich-Epstein A, Fu J, Koul D, Yao J, Saito N, Zheng S, Verhaak R, Lu Z, Yung WKA, Gomez G, Volinia S, Croce C, Brennan C, Cavenee W, Furnari F, Lopez SG, Qu D, Petritsch C, Gonzalez-Huarriz M, Aldave G, Ravi D, Rubio A, Diez-Valle R, Marigil M, Jauregi P, Vera B, Rocha AADL, Tejada-Solis S, Alonso MM, Gopal U, Isaacs J, Gruber-Olipitz M, Dabral S, Ramkissoon S, Kung A, Pak E, Chung J, Theisen M, Sun Y, Monrose V, Franchetti Y, Sun Y, Shulman D, Redjal N, Tabak B, Beroukhim R, Zhao J, Buonamici S, Ligon K, Kelleher J, Segal R, Haas B, Canton D, Diaz P, Scott J, Stella N, Hara K, Kageji T, Mizobuchi Y, Kitazato K, Okazaki T, Fujihara T, Nakajima K, Mure H, Kuwayama K, Hara T, Nagahiro S, Hill L, Botfield H, Hossain-Ibrahim K, Logan A, Cruickshank G, Liu Y, Gilbert M, Kyprianou N, Rangnekar V, Horbinski C, Hu Y, Vo C, Li Z, Ke C, Ru N, Hess KR, Linskey ME, Zhou YAH, Hu F, Vinnakota K, Wolf S, Kettenmann H, Jackson PJ, Larson JD, Beckmann DA, Moriarity BS, Largaespada DA, Jalali S, Agnihotri S, Singh S, Burrell K, Croul S, Zadeh G, Kang SH, Yu MO, Song NH, Park KJ, Chi SG, Chung YG, Kim SK, Kim JW, Kim JY, Kim JE, Choi SH, Kim TM, Lee SH, Kim SK, Park SH, Kim IH, Park CK, Jung HW, Koldobskiy M, Ahmed I, Ho G, Snowman A, Raabe E, Eberhart C, Snyder S, Agnihotri S, Gugel I, Remke M, Bornemann A, Pantazis G, Mack S, Shih D, Sabha N, Taylor M, Tatagiba M, Zadeh G, Krischek B, Schulte A, Liffers K, Kathagen A, Riethdorf S, Westphal M, Lamszus K, Lee JS, Xiao J, Patel P, Schade J, Wang J, Deneen B, Erdreich-Epstein A, Song HR, Leiss L, Gjerde C, Saed H, Rahman A, Lellahi M, Enger PO, Leung R, Gil O, Lei L, Canoll P, Sun S, Lee D, Ho ASW, Pu JKS, Zhang XQ, Lee NP, Dat PJR, Leung GKK, Loetsch D, Steiner E, Holzmann K, Spiegl-Kreinecker S, Pirker C, Hlavaty J, Petznek H, Hegedus B, Garay T, Mohr T, Sommergruber W, Grusch M, Berger W, Lukiw WJ, Jones BM, Zhao Y, Bhattacharjee S, Culicchia F, Magnus N, Garnier D, Meehan B, McGraw S, Hashemi M, Lee TH, Milsom C, Gerges N, Jabado N, Trasler J, Pawlinski R, Mackman N, Rak J, Maherally Z, Thorne A, An Q, Barbu E, Fillmore H, Pilkington G, Maherally Z, Tan SL, Tan S, An Q, Fillmore H, Pilkington G, Malhotra A, Choi S, Potts C, Ford DA, Nahle Z, Kenney AM, Matlaf L, Khan S, Zider A, Singer E, Cobbs C, Soroceanu L, McFarland BC, Hong SW, Rajbhandari R, Twitty GB, Gray GK, Yu H, Benveniste EN, Nozell SE, Minata M, Kim S, Mao P, Kaushal J, Nakano I, Mizowaki T, Sasayama T, Tanaka K, Mizukawa K, Nishihara M, Nakamizo S, Tanaka H, Kohta M, Hosoda K, Kohmura E, Moeckel S, Meyer K, Leukel P, Bogdahn U, Riehmenschneider MJ, Bosserhoff AK, Spang R, Hau P, Mukasa A, Watanabe A, Ogiwara H, Saito N, Aburatani H, Mukherjee J, Obha S, See W, Pieper R, Nakajima K, Hara K, Kageji T, Mizobuchi Y, Kitazato K, Fujihara T, Otsuka R, Kung D, Nagahiro S, Rajbhandari R, Sinha T, Meares G, Benveniste EN, Nozell S, Ott M, Litzenburger U, Rauschenbach K, Bunse L, Pusch S, Ochs K, Sahm F, Opitz C, von Deimling A, Wick W, Platten M, Peruzzi P, Chiocca EA, Godlewski J, Read R, Fenton T, Gomez G, Wykosky J, Vandenberg S, Babic I, Iwanami A, Yang H, Cavenee W, Mischel P, Furnari F, Thomas J, Ronellenfitsch MW, Thiepold AL, Harter PN, Mittelbronn M, Steinbach JP, Rybakova Y, Kalen A, Sarsour E, Goswami P, Silber J, Harinath G, Aldaz B, Fabius AWM, Turcan S, Chan TA, Huse JT, Sonabend AM, Bansal M, Guarnieri P, Lei L, Soderquist C, Leung R, Yun J, Kennedy B, Sisti J, Bruce S, Bruce R, Shakya R, Ludwig T, Rosenfeld S, Sims PA, Bruce JN, Califano A, Canoll P, Stockhausen MT, Kristoffersen K, Olsen LS, Poulsen HS, Stringer B, Day B, Barry G, Piper M, Jamieson P, Ensbey K, Bruce Z, Richards L, Boyd A, Sufit A, Burleson T, Le JP, Keating AK, Sundstrom T, Varughese JK, Harter P, Prestegarden L, Petersen K, Azuaje F, Tepper C, Ingham E, Even L, Johnson S, Skaftnesmo KO, Lund-Johansen M, Bjerkvig R, Ferrara K, Thorsen F, Takeshima H, Yamashita S, Yokogami K, Mizuguchi S, Nakamura H, Kuratsu J, Fukushima T, Morishita K, Tanaka H, Sasayama T, Tanaka K, Nakamizo S, Mizukawa K, Kohmura E, Tang Y, Vaka D, Chen S, Ponnuswami A, Cho YJ, Monje M, Tateishi K, Narita Y, Nakamura T, Cahill D, Kawahara N, Ichimura K, Tiemann K, Hedman H, Niclou SP, Timmer M, Tjiong R, Rohn G, Goldbrunner R, Timmer M, Tjiong R, Stavrinou P, Rohn G, Perrech M, Goldbrunner R, Tokita M, Mikheev S, Sellers D, Mikheev A, Kosai Y, Rostomily R, Tritschler I, Seystahl K, Schroeder JJ, Weller M, Wade A, Robinson AE, Phillips JJ, Gong Y, Ma Y, Cheng Z, Thompson R, Wang J, Fan QW, Cheng C, Gustafson W, Charron E, Zipper P, Wong R, Chen J, Lau J, Knobbe-Thosen C, Weller M, Jura N, Reifenberger G, Shokat K, Weiss W, Wu S, Fu J, Zheng S, Koul D, Yung WKA, Wykosky J, Hu J, Taylor T, Villa GR, Gomez G, Mischel PS, Gonias SL, Cavenee W, Furnari F, Yamashita D, Kondo T, Takahashi H, Inoue A, Kohno S, Harada H, Ohue S, Ohnishi T, Li P, Ng J, Yuelling L, Du F, Curran T, Yang ZJ, Zhu D, Castellino RC, Van Meir EG, Zhu W, Begum G, Wang Q, Clark P, Yang SS, Lin SH, Kahle K, Kuo J, Sun D. CELL BIOLOGY AND SIGNALING. Neuro Oncol 2013. [DOI: 10.1093/neuonc/not174] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|